;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Illumina, Actelion boost guidance

    Illumina Inc. (NASDAQ:ILMN) gained $2.1 billion in market cap on Tuesday in the wake of its earnings release after market on Monday. The shares added $15.08 to $179.55 after the sequencing company said revenue jumped 35…

    Published on 10/21/2014
  • FINANCIAL NEWS: Tobira amends IPO

    Tobira Therapeutics Inc. (San Francisco, Calif.) amended the terms for its proposed IPO on NASDAQ underwritten by Oppenheimer & Co., removing the price range, the number of shares and several of the underwriters. The …

    Published on 10/21/2014
  • FINANCIAL NEWS: Unum launches with $12M series A

    Oncology play Unum Therapeutics (Cambridge, Mass.) raised $12 million in a series A round led by Atlas Venture and Fidelity Biosciences. Sanofi-Genzyme BioVentures also participated.Unum uses its antibody-coupled T cell…

    Published on 10/21/2014
  • FINANCIAL NEWS: Viamet replaces IPO with $60M D round

    One day after withdrawing a proposed IPO, Viamet Pharmaceuticals Inc. (Durham, N.C.) closed a $60 million series D round led by new investor Brandon Point Industries Ltd. working with Woodford Investment Management. The…

    Published on 10/21/2014
  • FINANCIAL NEWS: DBV sets terms for dual listing

    DBV Technologies (Euronext:DBV) finalized the details of its planned global offering of shares that will include a dual-listing of ADSs on NASDAQ. The allergy specialist now plans to sell up to 2.7 million ordinary …

    Published on 10/20/2014
  • FINANCIAL NEWS: HealthCare Royalty Partners closes $1.5B fund

    HealthCare Royalty Partners closed its third fund, HealthCare Royalty Partners III, at $1.5 billion, which the firm said exceeded its original target by over 75%. Managing Partner Todd David told BioCentury the firm …

    Published on 10/20/2014
  • FINANCIAL NEWS: PureTech raises $55M

    Science and technology development firm PureTech Ventures (Boston, Mass.) raised $55 million from Invesco Perpetual and other investors including endowments, angels and pharma companies. The funding builds on about $32…

    Published on 10/20/2014
  • FINANCIAL NEWS: Viamet withdraws IPO

    Viamet Pharmaceuticals Inc. (Durham, N.C.) withdrew its proposed IPO on NASDAQ. The company did not provide a reason in its SEC filing and did not respond to inquiries. In July, the infectious disease play filed to …

    Published on 10/20/2014
  • FINANCIAL NEWS: Neothetics, PolyPid file for IPOs

    Neothetics Inc. (San Diego, Calif.) and PolyPid Ltd. (Petach Tikva, Israel) filed for IPOs on NASDAQ. Neothetics filed to raise up to $63.3 million with Piper Jaffray; Guggenheim Securities; and Needham as underwriters…

    Published on 10/17/2014
  • FINANCIAL NEWS: Tetraphase prices $75M follow-on

    Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) climbed $4 (20%) to $24.11 on Friday after announcing it has priced the sale of 3.95 million shares at $19 in a follow-on that is expected to close Oct. 22. The company …

    Published on 10/17/2014
  • FINANCIAL NEWS: Atara raises $55M in IPO

    Atara Biotherapeutics Inc. (NASDAQ:ATRA) was down $0.35 to $10.65 in its first day of trading Thursday after it raised $55 million through the sale of 5 million shares at $11 in an IPO. The price valued Atara at $213.4 …

    Published on 10/16/2014
  • FINANCIAL NEWS: Dance withdraws IPO

    Dance Biopharm Inc. (Brisbane, Calif.) withdrew its proposed IPO on NASDAQ. The diabetes company did not provide a reason in its SEC filing. In April, the company filed to raise up to $75 million in a deal …

    Published on 10/16/2014
  • FINANCIAL NEWS: Esperion haircut after $85M follow-on

    Esperion Therapeutics Inc. (NASDAQ:ESPR) lost $2.56 (11%) to $20.69 after it raised $85 million through the sale of 4.3 million shares at $20 in a follow-on underwritten by J.P. Morgan; BofA Merrill Lynch; JMP …

    Published on 10/16/2014
  • FINANCIAL NEWS: Forward Pharma raises $220.5M in IPO

    Forward Pharma A/S (NASDAQ:FWP) fell $3.50 (17%) to $17.50 in its first day of trading on Wednesday after it raised $220.5 million through the sale of 10.5 million American Depositary Shares (ADSs) at $21 in an IPO. …

    Published on 10/15/2014
  • FINANCIAL NEWS: Bicycle raising L20M A round

    Bicycle Therapeutics Ltd. (Cambridge, U.K.) raised an undisclosed amount of a planned L20 million ($32.2 million) series A round from existing investors Atlas Venture; Novartis Venture Fund; SR One; SV Life Sciences; …

    Published on 10/14/2014
  • FINANCIAL NEWS: Cancer play Rigontec raises EUR 9.5M

    Rigontec GmbH (Siegburg, Germany) raised EUR 9.5 million ($12 million) in the first close of a series A round co-led by Wellington Partners and Boehringer Ingelheim Venture Fund. NRW Bank and High-Tech Greunderfonds …

    Published on 10/14/2014
  • FINANCIAL NEWS: DNAtrix raises $20M in series B

    Cancer play DNAtrix Inc. (Houston, Texas) raised $20 million in an untranched series B round led by new investor Morningside Ventures. Existing investors Mercury Fund, Targeted Technology Fund and unnamed others also …

    Published on 10/14/2014
  • FINANCIAL NEWS: Esperion planning $85M follow-on

    Esperion Therapeutics Inc. (NASDAQ:ESPR) proposed to raise up to $85 million in a follow-on underwritten by J.P. Morgan and BofA Merrill Lynch. The offering will help fund Phase III testing of ETC-1002, which is an …

    Published on 10/14/2014
  • FINANCIAL NEWS: Raze debuts with $24M series A

    Raze Therapeutics Inc. (Cambridge, Mass.) raised $24 million in a series A round with Atlas Venture; MPM Capital; MS Ventures; Partners Innovation Fund; Astellas Venture Management; and Novartis AG (NYSE:NVS; SIX:NOVN…

    Published on 10/14/2014
  • FINANCIAL NEWS: Anatara raises A$7M in Australian IPO

    Anatara Lifesciences Ltd. (ASX:ANR), which is seeking partners for human development of its non-antibiotic therapy to treat and prevent diarrhea, raised A$7 million ($6.1 million) through the sale of 14 million shares …

    Published on 10/13/2014
  • FINANCIAL NEWS: Invitae raises $120M in F round

    Invitae Corp. (San Francisco, Calif.) raised $120 million in a series F round to build out its one-stop genetic testing service. The company aims to aggregate a complete catalog of genetic diagnostic tests and offer …

    Published on 10/13/2014
  • FINANCIAL NEWS: Nextech raises $40M for Oncology IV fund

    Nextech Invest Ltd. raised the first $40 million of its planned $100 million Oncology IV fund, which it expects to close in the next 12 months. The firm intends to invest in eight to 10 companies developing cancer …

    Published on 10/13/2014
  • FINANCIAL NEWS: Probiodrug sets IPO terms

    Probiodrug AG (Halle/Saale, Germany) set a price range for its proposed IPO on Euronext Amsterdam. The Alzheimer's company plans to sell 1.5 million shares at EUR 15.25-EUR 19. At the midpoint price of EUR 17.13, …

    Published on 10/10/2014
  • FINANCIAL NEWS: PTC raises $108.8M in follow-on

    PTC Therapeutics Inc. (NASDAQ:PTCT) added $108.8 million to its coffers with its second big follow-on of 2014, selling 3 million shares at $36.25 in a deal underwritten by Credit Suisse; Citigroup; Cowen; Deutsche Bank;…

    Published on 10/10/2014
  • FINANCIAL NEWS: AutoGenomics files for IPO

    AutoGenomics Inc. (Vista, Calif.) filed to raise up to $60 million in an IPO on NASDAQ underwritten by Stifel; Canaccord Genuity; and Cantor Fitzgerald. The IPO filing is the company's third attempt to go public. …

    Published on 10/8/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993